Keywords: pfizer, geodon, equally, effective, better-tolerated, risperdal, patients

Pfizer's Geodon equally effective, better-tolerated than J&J's Risperdal in

Article | 31 January 2005

Print This

Patients with schizophrenia found Pfizer's atypical antipsychotic Geodon (ziprasidone) to be more tolerable than - and just as effective as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in